FAQs on 3D Printing of Medical Devices
3D Printing and coronavirus testing
As mentioned by Todd Goldstein, director of design and innovation at Northwell, Yahoo Finance, “First it was the kits, then it became the reagents [in short supply], then it became the swabs. We couldn’t print the kits or the reagents. It’s tough; everyone wants the same supplies at the same time.”
The FDA is willing to discuss these and other issues with manufacturers and facilities. Entities should email COVIDManufacturing@fda.hhs.gov for more information.
How 3D-printing is playing a role in coronavirus testing
This entry was posted in "Additive Manufacturing Dynamics in 3D/4D Printing and AI Research Collaborations", "Cross-disciplinary Innovations: 3D Printing, 4D Printing, Biotechnology, and Robotics", "Evolution of Printing Technologies: Celebrating the Emergence of 3D/4D/5D Printing with Insights and Community Events", "Guidelines, Regulations, and SV3DPrinter.com Policy on Additive Manufacturing.", "Optimizing Patient Treatment with Additive Manufacturing: Exploring 3D Printing in Healthcare" and tagged 3D printing and coronavirus testing, and Parts During the COVID-19 Pandemic, FAQs on 3D Printing of Medical Devices, FDA, How 3D-printing is playing a role in coronavirus testing, Northwell, Todd Goldstein, Yahoo Finance.